350 related articles for article (PubMed ID: 32958021)
1. β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer's disease pathology.
Shippy DC; Wilhelm C; Viharkumar PA; Raife TJ; Ulland TK
J Neuroinflammation; 2020 Sep; 17(1):280. PubMed ID: 32958021
[TBL] [Abstract][Full Text] [Related]
2. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Youm YH; Nguyen KY; Grant RW; Goldberg EL; Bodogai M; Kim D; D'Agostino D; Planavsky N; Lupfer C; Kanneganti TD; Kang S; Horvath TL; Fahmy TM; Crawford PA; Biragyn A; Alnemri E; Dixit VD
Nat Med; 2015 Mar; 21(3):263-9. PubMed ID: 25686106
[TBL] [Abstract][Full Text] [Related]
3. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
5. The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome.
Shang S; Wang L; Zhang Y; Lu H; Lu X
Cell Mol Neurobiol; 2018 Nov; 38(8):1479-1489. PubMed ID: 30218403
[TBL] [Abstract][Full Text] [Related]
6. The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia.
Deora V; Albornoz EA; Zhu K; Woodruff TM; Gordon R
J Neuroimmune Pharmacol; 2017 Dec; 12(4):568-574. PubMed ID: 28836226
[TBL] [Abstract][Full Text] [Related]
7. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
Qiu WQ; Pan R; Tang Y; Zhou XG; Wu JM; Yu L; Law BY; Ai W; Yu CL; Qin DL; Wu AG
Biomed Pharmacother; 2020 Oct; 130():110575. PubMed ID: 32768883
[TBL] [Abstract][Full Text] [Related]
8. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
9. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
[TBL] [Abstract][Full Text] [Related]
10. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
11. The ketone body β-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation.
Wu Y; Teng Y; Zhang C; Pan Y; Zhang Q; Zhu X; Liu N; Su X; Lin J
J Nanobiotechnology; 2022 Mar; 20(1):120. PubMed ID: 35264201
[TBL] [Abstract][Full Text] [Related]
12. β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.
Goldberg EL; Asher JL; Molony RD; Shaw AC; Zeiss CJ; Wang C; Morozova-Roche LA; Herzog RI; Iwasaki A; Dixit VD
Cell Rep; 2017 Feb; 18(9):2077-2087. PubMed ID: 28249154
[TBL] [Abstract][Full Text] [Related]
13. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
14. The ketone body β-hydroxybutyrate shifts microglial metabolism and suppresses amyloid-β oligomer-induced inflammation in human microglia.
Jin LW; Di Lucente J; Ruiz Mendiola U; Suthprasertporn N; Tomilov A; Cortopassi G; Kim K; Ramsey JJ; Maezawa I
FASEB J; 2023 Nov; 37(11):e23261. PubMed ID: 37878335
[TBL] [Abstract][Full Text] [Related]
15. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
[TBL] [Abstract][Full Text] [Related]
16. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.
Yin J; Zhao F; Chojnacki JE; Fulp J; Klein WL; Zhang S; Zhu X
Mol Neurobiol; 2018 Mar; 55(3):1977-1987. PubMed ID: 28255908
[TBL] [Abstract][Full Text] [Related]
18. Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: A narrative review.
Neudorf H; Little JP
Biomed J; 2024 Feb; 47(1):100677. PubMed ID: 37940045
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 inflammasome in Alzheimer's disease.
Tan MS; Yu JT; Jiang T; Zhu XC; Tan L
Mol Neurobiol; 2013 Dec; 48(3):875-82. PubMed ID: 23686772
[TBL] [Abstract][Full Text] [Related]
20. Oleocanthal-Rich Extra-Virgin Olive Oil Restores the Blood-Brain Barrier Function through NLRP3 Inflammasome Inhibition Simultaneously with Autophagy Induction in TgSwDI Mice.
Al Rihani SB; Darakjian LI; Kaddoumi A
ACS Chem Neurosci; 2019 Aug; 10(8):3543-3554. PubMed ID: 31244050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
